Ivette Estay

1.5k total citations
5 papers, 537 citations indexed

About

Ivette Estay is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ivette Estay has authored 5 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Ivette Estay's work include Cancer-related Molecular Pathways (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Telomeres, Telomerase, and Senescence (1 paper). Ivette Estay is often cited by papers focused on Cancer-related Molecular Pathways (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Telomeres, Telomerase, and Senescence (1 paper). Ivette Estay collaborates with scholars based in United States, Poland and Italy. Ivette Estay's co-authors include Peter K. Jackson, Erik G. Huntzicker, Anthony E. Oro, Hanson H. Zhen, Colleen Kemp, Dean Ornish, Nancy K. Hills, Elizabeth H. Blackburn, Steven J. Frenda and Jue Lin and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and Circulation Research.

In The Last Decade

Ivette Estay

5 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivette Estay United States 4 206 183 74 67 58 5 537
Lathika Mohanraj United States 8 261 1.3× 302 1.7× 95 1.3× 90 1.3× 40 0.7× 16 663
Inge Van Pottelbergh Belgium 17 320 1.6× 144 0.8× 24 0.3× 128 1.9× 193 3.3× 33 1000
Elias Salfati United States 9 243 1.2× 64 0.3× 35 0.5× 28 0.4× 237 4.1× 14 583
Katarina Nordfjäll Sweden 11 242 1.2× 904 4.9× 338 4.6× 44 0.7× 36 0.6× 11 1.1k
C. Maubaret United Kingdom 13 239 1.2× 308 1.7× 83 1.1× 6 0.1× 33 0.6× 19 618
Laila Bendix Denmark 14 146 0.7× 349 1.9× 119 1.6× 17 0.3× 10 0.2× 23 544
Jenni Brumelle United States 6 73 0.4× 139 0.8× 54 0.7× 21 0.3× 14 0.2× 6 317
Sodbo Sharapov Russia 11 164 0.8× 65 0.4× 36 0.5× 15 0.2× 105 1.8× 21 429
WM Drake United Kingdom 10 92 0.4× 84 0.5× 14 0.2× 21 0.3× 81 1.4× 13 576
Katherine A. Blackwell United States 8 197 1.0× 84 0.5× 7 0.1× 69 1.0× 47 0.8× 11 607

Countries citing papers authored by Ivette Estay

Since Specialization
Citations

This map shows the geographic impact of Ivette Estay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivette Estay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivette Estay more than expected).

Fields of papers citing papers by Ivette Estay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivette Estay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivette Estay. The network helps show where Ivette Estay may publish in the future.

Co-authorship network of co-authors of Ivette Estay

This figure shows the co-authorship network connecting the top 25 collaborators of Ivette Estay. A scholar is included among the top collaborators of Ivette Estay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivette Estay. Ivette Estay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Srivastava, Minu K., Velimir Gayevskiy, Ivette Estay, et al.. (2023). 606 IMpower110: Tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first-line atezolizumab or chemotherapy. SHILAP Revista de lepidopterología. A690–A690. 3 indexed citations
2.
3.
Banthia, Rajni, et al.. (2010). The Effectiveness and Efficacy of an Intensive Cardiac Rehabilitation Program in 24 Sites. American Journal of Health Promotion. 24(4). 260–266. 51 indexed citations
4.
Huntzicker, Erik G., et al.. (2006). Dual degradation signals control Gli protein stability and tumor formation. Genes & Development. 20(3). 276–281. 153 indexed citations
5.
Deng, David, Anya Tsalenko, Aditya Vailaya, et al.. (2005). Differences in Vascular Bed Disease Susceptibility Reflect Differences in Gene Expression Response to Atherogenic Stimuli. Circulation Research. 98(2). 200–208. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lathika Mohanraj Breakdown of academic impact, for papers by Inge Van Pottelbergh Breakdown of academic impact, for papers by Elias Salfati Breakdown of academic impact, for papers by Katarina Nordfjäll Breakdown of academic impact, for papers by C. Maubaret Breakdown of academic impact, for papers by Laila Bendix Breakdown of academic impact, for papers by Jenni Brumelle Breakdown of academic impact, for papers by Sodbo Sharapov Breakdown of academic impact, for papers by WM Drake Breakdown of academic impact, for papers by Katherine A. Blackwell
Rankless by CCL
2026